Long-term pattern of HIV-1 RNA load in perinatally infected children

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 4, 1999, Pages 337-343

  Navér, Lars ^a,b   Ehrnst, Anneka ^a,b   Belfrage, Erik ^a   Sönnerborg, Anders ^a   Lidin Janson, Gunilla ^c   Christensson, Bertil ^d   Ljung, Rolf ^d   Bohlin, Ann Britt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA; ZIDOVUDINE;

AGE; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; NEWBORN; PERINATAL INFECTION; PREDICTION; TREATMENT PLANNING; VERTICAL TRANSMISSION; VIRUS LOAD;

CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; DISEASE PROGRESSION; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LINEAR MODELS; MALE; MONITORING, PHYSIOLOGIC; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SWEDEN; VIRAL LOAD; VIREMIA; ZIDOVUDINE;

EID: 0032846805     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549950163743     Document Type: Article

References (24)

1. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-70.
2. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, et al. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society - USA panel. JAMA 1997; 277: 1962-9.
3. De Rossi A, Masiero S, Giaquinto C, Ruga E, Comar M, Giacca M, et al. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest 1996; 97: 323-30.
4. + lymphocyte count in HIV-infected infants and children. JAMA 1998; 279: 756-61.
5. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med 1997; 336: 1337-42.
6. Valentine ME, Jackson CR, Vavro C, Wilfert CM, McClernon D, et al. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis J 1998; 17: 18-23.
7. McIntosh K, Shevitz A, Zaknun D, Kornegay J, Chatis P, Karthas N, et al. Age-and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus. Pediatr Infect Dis J 1996; 15: 1087-91.
8. Paediatric European Network for Treatment of AIDS (PENTA). HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. AIDS 1998; 12: F1-8.
9. The European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 1994; 94: 815-9.
10. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331: 1173-80.
11. Connor EM, Mofenson LM. Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: pediatric AIDS Clinical Trials Group Protocol 076 - results and treatment recommendations. Pediatr Infect Dis J 1995; 14: 536-41.
12. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep 1994; 43: 1-10.
13. van Gemen B, v d Wiel P, van Beuningen R, Sillekens P, Jurriaans S. Dries C, et al. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Appl 1995; 4: S177-84.
14. Leitner T, Korovina G, Marquina S, Smolskaya T, Albert J. Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant. AIDS Res Hum Retroviruses 1996; 12: 1595-603.
15. Goudsmit J. Prevention and clinical management of AIDS. In: The NASBA experience in HIV-1 quantification. Amsterdam: Amsterdam University Press, 1996: 40-1.
16. Ginocchio CC, Wang XP, Kaplan MH. Mulligan G, Witt D, Romano JW, et al. Effects of specimen collection, processing, and storage conditions on stability of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1997; 35: 2886-93.
17. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997; 11: 199-202.
18. Alaeus A, Lidman K, Sönnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 1997; 11: 859-65.
19. Oudshoorn P, Jacobs F, Ehren R, de Baar M, van Aarle P, de Ronde T. Detection and quantitation of HIV-1 variants by a LTR-based NASBA assay. 12th World AIDS Conference. Geneva, June 28-July 3 1998 (abstract 41258).
20. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh C, Thior I, Barin F, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 1999; 179: 68-73.
21. Dickover RE, Dillon M, Gillette SG, Deveikis A, Keller M, Plaeger-Marshall S, et al. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis 1994; 170: 1279-84.
22. Daar ES, Moudgil T, Meyer RD, Ho DD Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991; 324: 961-4.
23. Henrard DR, Phillips JF, Muenz LR, Blattner WA, Wiesner D, Eyster ME, et al. Natural history of HIV-1 cell-free viremia. JAMA 1995; 274: 554-8.
24. + lymphocyte counts above 500 × 10(6)/1. AIDS 1997; 11: 53-7.